Area of research
Oncology · Cancer Research
Research interest
Research interests include Cancer-related molecular mechanisms research, Ferroptosis and cancer prognosis, Cancer Immunotherapy and Biomarkers, and RNA modifications and cancer.
A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy
N6-methyladenosine-modified VGLL1 promotes ovarian cancer metastasis through high-mobility group AT-hook 1/Wnt/β-catenin signaling
N6-Methyladenosine-Modified VGLL1 Promotes Ovarian Cancer Metastasis Through HMGA1/Wnt/β-Catenin Signaling
Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy
CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype
Dihydroartemisinin attenuates pulmonary inflammation and fibrosis in rats by suppressing JAK2/STAT3 signaling
N6-methyladenosine-modified VGLL1 promotes ovarian cancer metastasis through HMGA1/Wnt/β-catenin signaling
Fibroblastic galectin-1-fostered invasion and metastasis are mediated by TGF-β1-induced epithelial-mesenchymal transition in gastric cancer